These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 18639460)
1. UnPAKing the class differences among p21-activated kinases. Eswaran J; Soundararajan M; Kumar R; Knapp S Trends Biochem Sci; 2008 Aug; 33(8):394-403. PubMed ID: 18639460 [TBL] [Abstract][Full Text] [Related]
2. Targeting group II PAKs in cancer and metastasis. Eswaran J; Soundararajan M; Knapp S Cancer Metastasis Rev; 2009 Jun; 28(1-2):209-17. PubMed ID: 19160016 [TBL] [Abstract][Full Text] [Related]
6. Emerging functions of p21-activated kinases in human cancer cells. Kumar R; Vadlamudi RK J Cell Physiol; 2002 Nov; 193(2):133-44. PubMed ID: 12384990 [TBL] [Abstract][Full Text] [Related]
7. P21-activated kinase 4--not just one of the PAK. Dart AE; Wells CM Eur J Cell Biol; 2013; 92(4-5):129-38. PubMed ID: 23642861 [TBL] [Abstract][Full Text] [Related]
8. Molecular and functional characterization of EhPAK3, a p21 activated kinase from Entamoeba histolytica. Dutta S; Sardar A; Ray D; Raha S Gene; 2007 Nov; 402(1-2):57-67. PubMed ID: 17761392 [TBL] [Abstract][Full Text] [Related]
9. p21-activated kinases: three more join the Pak. Jaffer ZM; Chernoff J Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587 [TBL] [Abstract][Full Text] [Related]
10. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases. Ha BH; Morse EM; Turk BE; Boggon TJ J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of p21-activated kinases (PAKs). Rudolph J; Crawford JJ; Hoeflich KP; Wang W J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869 [TBL] [Abstract][Full Text] [Related]
12. P21 activated kinase signaling in cancer. Rane CK; Minden A Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094 [TBL] [Abstract][Full Text] [Related]
13. A tale of two Paks. Arias-Romero LE; Chernoff J Biol Cell; 2008 Feb; 100(2):97-108. PubMed ID: 18199048 [TBL] [Abstract][Full Text] [Related]
14. Pak protein kinases and their role in cancer. Dummler B; Ohshiro K; Kumar R; Field J Cancer Metastasis Rev; 2009 Jun; 28(1-2):51-63. PubMed ID: 19165420 [TBL] [Abstract][Full Text] [Related]
15. p21-Activated kinase 5: a pleiotropic kinase. Wen YY; Wang XX; Pei DS; Zheng JN Bioorg Med Chem Lett; 2013 Dec; 23(24):6636-9. PubMed ID: 24215894 [TBL] [Abstract][Full Text] [Related]
16. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer. Shao YG; Ning K; Li F World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660 [TBL] [Abstract][Full Text] [Related]
17. Rho family GTPase signaling through type II p21-activated kinases. Chetty AK; Ha BH; Boggon TJ Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658 [TBL] [Abstract][Full Text] [Related]
18. PAK signalling in neuronal physiology. Kreis P; Barnier JV Cell Signal; 2009 Mar; 21(3):384-93. PubMed ID: 19036346 [TBL] [Abstract][Full Text] [Related]
19. Structure, biochemistry, and biology of PAK kinases. Kumar R; Sanawar R; Li X; Li F Gene; 2017 Mar; 605():20-31. PubMed ID: 28007610 [TBL] [Abstract][Full Text] [Related]
20. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion. McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]